Plant-based compounds could treat chronic pain in Parkinson’s, study finds

News

Author: Sophie BatesPublished: 12 March 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

A six-year study has found that chronic pain in people with Parkinson’s is linked to a gene involved with how the brain responds to cannabis compounds.  

The investigation examined why some people with the condition experience persistent pain – and the impact it has on their work, daily life and social relationships. Conducted by researchers at Manchester’s Salford Royal Foundation Trust, UK, and funded by Parkinson’s UK, it is the largest study to investigate chronic pain in people with Parkinson’s.

Dr Monty Silverdale, consultant neurologist at Greater Manchester Centre, said: “This study is significant because it shows the important role of genetics in chronic pain in Parkinson’s.

“Our findings suggest that cannabis-based compounds may be worth investigating as a treatment for pain in Parkinson’s.”


Read more: 

 Could playing table tennis help reduce Parkinson’s symptoms?

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Go Back

Share this story

Comments


Related articles


Perspectives

Who said what: QoTW 04.06.15

Our favourite quotes of the week from around the web

READ MORE
Parkinson's UK audit 2015 lead

PD in Practice

Over 1/3 of patients don’t receive enough info about Parkinson’s at diagnosis

Parkinson’s UK outlines key areas for improvement in care in audit

READ MORE

Health & Fitness

How tailored exercise programmes can help people with Parkinson’s

How to find the right Parkinson’s exercise programme

READ MORE